gentian violet and Benign Mastocytoma

gentian violet has been researched along with Benign Mastocytoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assreuy, J; Costa, RS	1

Other Studies

1 other study(ies) available for gentian violet and Benign Mastocytoma

Article	Year
Nitric oxide inhibits irreversibly P815 cell proliferation: involvement of potassium channels. Cell proliferation, 2002, Volume: 35, Issue:6 Topics: Animals; Antineoplastic Agents; Cell Count; Cell Division; Coloring Agents; Cytoskeleton; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gentian Violet; Growth Inhibitors; Guanylate Cyclase; Kinetics; Mastocytoma; Mice; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Penicillamine; Potassium Channel Blockers; Potassium Channels; Tumor Cells, Cultured	2002

Article

Year

Nitric oxide inhibits irreversibly P815 cell proliferation: involvement of potassium channels.

Cell proliferation, 2002, Volume: 35, Issue:6

Topics: Animals; Antineoplastic Agents; Cell Count; Cell Division; Coloring Agents; Cytoskeleton; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gentian Violet; Growth Inhibitors; Guanylate Cyclase; Kinetics; Mastocytoma; Mice; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Penicillamine; Potassium Channel Blockers; Potassium Channels; Tumor Cells, Cultured

2002